STOCK TITAN

Cellebrite grants director 15,190 RSUs

Director Troy Richardson received a compensation-related RSU grant that will vest into additional Cellebrite DI Ltd. (CLBT) Ordinary Shares in 2027.

(Neutral)
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Cellebrite DI Ltd. (symbol: CLBT) is the issuer of record for a Form 4 filing submitted to the SEC. Richardson Troy reported acquisition or exercise transactions in this Form 4 filing.

Cellebrite DI Ltd. (CLBT) reported that director Troy Richardson received a grant of 15,190 restricted share units (RSUs) on September 17, 2026. The RSUs will vest on September 17, 2027, with each RSU settling into one Ordinary Share. Following this award, Richardson directly holds 36,164 Ordinary Shares. The grant carries a stated price of $0.00 per share, indicating a compensation-related equity award rather than a market purchase.

Positive

  • None.

Negative

  • None.
Insider Richardson Troy
Role Director
Type Security Shares Price Value
Grant/Award Ordinary shares, par value NIS 0.00001 F1 15,190 $0.00 $0.00
Holdings After Transaction: Ordinary shares, par value NIS 0.00001 — 36,164 shares (Direct)
Footnotes (1)
  1. F1. Represents an award of restricted share units ("RSUs") that will vest on September 17, 2027. Each RSU represents a contingent right to receive one Ordinary Share of the Issuer upon settlement.
RSUs granted 15,190 units Restricted share units granted to director on September 17, 2026
Shares following transaction 36,164 shares Ordinary Shares directly held by Troy Richardson after the grant
Grant price per share $0.00 per share Stated price for RSU grant, indicating a compensation award
RSU vesting date September 17, 2027 Date when the 15,190 RSUs are scheduled to vest
restricted share units ("RSUs") financial
"Represents an award of restricted share units ("RSUs") that will vest"
contingent right financial
"Each RSU represents a contingent right to receive one Ordinary Share"
Ordinary Share financial
"Each RSU represents a contingent right to receive one Ordinary Share"
An ordinary share is a unit of ownership in a company that gives the holder a stake in its profits and usually the right to vote on key decisions. Think of it like a slice of a pizza where each slice entitles you to a portion of what’s left after bills are paid; value can rise or fall with the business and may pay dividends, so it matters to investors for income, growth and control.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did director Troy Richardson report in this Form 4 for CLBT?

He reported a grant of 15,190 restricted share units (RSUs) of Cellebrite DI Ltd. on September 17, 2026, which will vest into Ordinary Shares at a future date as specified in the award terms.

When do Troy Richardson’s new RSUs in CLBT vest?

The filing states the 15,190 RSUs will vest on September 17, 2027. Upon vesting and settlement, each RSU will convert into one Ordinary Share of Cellebrite DI Ltd.

How many Cellebrite (CLBT) shares does Troy Richardson hold after this RSU grant?

After the reported RSU grant, Troy Richardson directly holds 36,164 Ordinary Shares of Cellebrite DI Ltd., according to the Form 4 disclosure.

Was Troy Richardson’s CLBT RSU grant a market purchase or a compensation award?

It was reported as a grant or award acquisition, with a stated price of $0.00 per share, indicating equity compensation rather than a market purchase of Cellebrite shares.

Is Troy Richardson’s CLBT Form 4 transaction under a Rule 10b5-1 plan?

No Rule 10b5-1 trading plan is reported. The document-level checkbox for transactions under a Rule 10b5-1 plan is not marked as affirmative in this filing.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Richardson Troy

(Last)(First)(Middle)
94 SHLOMO SHMELZER ROAD

(Street)
PETAH TIKVA4970602

(City)(State)(Zip)

ISRAEL

(Country)
2. Issuer Name and Ticker or Trading Symbol
Cellebrite DI Ltd. [ CLBT ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
09/17/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Ordinary shares, par value NIS 0.0000109/17/2026A15,190(1)A$036,164D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Represents an award of restricted share units ("RSUs") that will vest on September 17, 2027. Each RSU represents a contingent right to receive one Ordinary Share of the Issuer upon settlement.
Remarks:
/s/ Troy Richardson09/17/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Keep reading